Streaming issues? Report here
John Maytham 2019 1500 BW John Maytham 2019 1500 BW
Afternoon Drive with John Maytham
15:00 - 18:00
volume_up
volume_mute

Up Next: The Money Show with Bruce Whitfield
See full line-up
Afternoon Drive with John Maytham
15:00 - 18:00
Home
arrow_forward
Business
fiber_manual_record
Lifestyle

Aspen Pharmacare has a plan to save South Africa’s vaccine rollout

14 June 2021 6:47 PM
Tags:
The Money Show
Aspen Pharmacare
Bruce Whitfield
Stephen Saad
Covid-19 vaccine rollout
Johnson & Johnson vaccine

The Money Show’s Bruce Whitfield interviews Stephen Saad, CEO at Aspen Pharmacare.
  • The country will get 2 million J&J vaccine doses over the next few weeks

  • New data shows the J&J vaccine remains effective against all variants


An over-60 gets vaccinated against Covid-19. © Jozef Polc/123rf.com

RELATED: 'We’re getting 300 000 J&J vaccines this week'


The South African Health Products Regulatory Authority (Sahpra) announced on Sunday that two million J&J vaccines ready for distribution will have to be destroyed after a US Food and Drug Administration (USFDA) notice of contamination at a J&J site in the United States.

It will take two weeks to replace the lost vaccines, said Aspen Pharmacare on Monday.

South Africa has ordered 31 million of the single-dose Covid-19 vaccine.

South Africa – epicentre of the pandemic on the Continent from the start, and in the grips of a third wave of Covid-19 infections – is struggling to speed up its mass vaccination programme.

South Africa recorded 7657 new cases of Covid-19 on Sunday and 59 deaths.

About 481 000 people (0.8% of the population) were fully vaccinated by Saturday (12 June).

The Money Show’s Bruce Whitfield interviewed Stephen Saad, CEO at Aspen Pharmacare (scroll up to listen).

I’m more relieved now than I was on Friday… In the next few days, we have 300 000 doses arriving from overseas to look after our teachers… We’ll get more than 2 million doses over the next few weeks… Supply will not be the issue…

Stephen Saad, CEO - Aspen Pharmacare

It’s important we’ll get stock to the rest of Africa as well…

Stephen Saad, CEO - Aspen Pharmacare

In South Africa, you won’t be able to vaccinate as quickly as we can manufacture… There’s only so much you can store…

Stephen Saad, CEO - Aspen Pharmacare

The J&J vaccine is proving to be fantastic [against all the variants] … The data has been so positive…

Stephen Saad, CEO - Aspen Pharmacare

Click here for all our Covid-19-related articles in one place.





14 June 2021 6:47 PM
Tags:
The Money Show
Aspen Pharmacare
Bruce Whitfield
Stephen Saad
Covid-19 vaccine rollout
Johnson & Johnson vaccine

More from Covid-19 coronavirus explained

More from Information about Covid-19 coronavirus